18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Current Radiopharmaceuticals

• Publication date

  2018-03-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1874471010666171108162319PMID 29119942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Molecular imaging of tumor hypoxia: Evolution of nitroimidazole radiopharmaceuticals and insights for future development.

  2023cites this paper
• Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy

  2023cites this paper
• Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy

  2022cites this paper
• 18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers

  2021cites this paper
• [Progress in the clinical application and correlation between glucose transporter-1 and 18F-FDG PET/CT imaging for non-small cell lung cancer].

  2021cites this paper
• First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer

  2021cites this paper
• Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI.

  2020cites this paper
• Hypoxia PET/CT and Colorectal Cancer: A Case Report

  2020cites this paper
• Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In Vivo

  2019influential citation
• Apport de l'imagerie fonctionelle par Tomographie par émissions de positons (TEP) en radiothérapie pulmonaire

  2018cites this paper
• Clinical imaging of hypoxia: Current status and future directions

  2018cites this paper